AstraZeneca (AZ) has announced that its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) has been approved ...

Alnylam Pharmaceuticals’ RNAi therapeutic vutrisiran has been recommended by the European Medicines Agency’s human medicines ...

Bristol Myers Squibb (BMS) has announced that an injectable version of its cancer immunotherapy Opdivo (nivolumab) has been ...

What impact can we expect from the abolition of NHS England (NHSE) and changes at the Department of Health and Social Care ...

AZ’s triple-combination therapy is already approved under the brand names Breztri Aerosphere and Trixeo Aerosphere to treat ...

The once-a-day drug has been recommended for patients with a history of previous medical or surgical treatment ...

Tina Hahn, who joined AXON in 2012 as Vice President, will now take on the role of AXON’s President and Managing Partner.

The network has introduced a new agency and aligned its medical communications, medical affairs and publications capabilities ...

AbbVie’s Rinvoq (upadacitinib) has been approved by the US Food and Drug Administration (FDA) to treat adults with giant cell ...

Connected patches can be used to monitor vital patient parameters in real time, including heart rate, oxygen saturation, ...

Now more than ever we need to remain focused on the real goals of DE&I – and whether we call it that or not, we surely must ...

Eli Lilly and Creyon Bio have entered into a partnership worth over $1bn to develop RNA-targeted oligonucleotide (oligo) ...